Fat infusions could help preterm babies breathe easier and develop better

NCT ID NCT06915441

First seen Jun 25, 2026 · Last updated Aug 07, 2026 · Updated 5 times

Summary

This study compares two types of fat infusions (mixed oil vs. soybean oil) given to extremely preterm infants to improve nutrition and reduce the risk of bronchopulmonary dysplasia (a chronic lung disease) and neurodevelopmental impairment. About 230 babies born before 28 weeks or weighing under 1000 grams will receive one of the two infusions. The goal is to see which one leads to better survival without lung disease and better development at age two.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
lipid emulsions (mixed oil or soybean oil)
What this could lead to
If it works, this could point toward a better way to feed extremely preterm babies, reducing their risk of chronic lung disease and developmental delays.
What could go wrong
This is a Phase 2 trial with 230 infants, so results are still early. The infusions may not show a clear benefit, and there are risks like infection or feeding intolerance.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BRONCHOPULMONARY DYSPLASIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • The University of Texas Health Science Center at Houston

    RECRUITING

    Houston, Texas, 77030, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.